Berkshire Hathaway
-

Berkshire Hathaway Expands Stake in Serial Acquirer Bending Spoons
Berkshire Hathaway invested $330 million more into Bending Spoons, driving the tech firm’s stock up 35% as acquisitions continue.
-

Buffett’s Final Berkshire Exit Highlights the Growing Tension Between Market Speed and Value Discipline
Warren Buffett’s Berkshire retirement ends an era of value investing, highlighting the tension between his legendary patience and today’s high-speed digital markets.
-

Warren Buffett Steps Down as Berkshire Hathaway Chairman
After more than 50 years at the helm, Warren Buffett has stepped down as chairman of Berkshire Hathaway, with his son Howard Buffett succeeding him immediately.
-

Berkshire Hathaway Breaks 14-Quarter Selling Streak as Greg Abel Deploys Capital
Berkshire Hathaway has ended a 14-quarter selling streak, with CEO Greg Abel deploying $19.8 billion in equities during the second quarter of 2026.
-

Warren Buffett Shifts Strategy, Commits $30 Billion to Alphabet Amid AI Infrastructure Push
Warren Buffett has pivoted Berkshire Hathaway’s strategy, committing $30 billion to Alphabet to capitalize on the massive growth in AI infrastructure demand.
-

Alphabet Initiates $80 Billion Capital Raise to Fuel AI Infrastructure Expansion
Alphabet has announced an $80 billion equity capital raise to accelerate AI infrastructure, including a $10 billion investment from Berkshire Hathaway, as the company grapples with unprecedented compute demand and rising capex requirements.
-

Post-Buffett Era: Global Markets Face New Uncertainty
As Berkshire Hathaway enters a new chapter without Warren Buffett, investors face shifting valuation models and questions of institutional stability.
-

Buffett’s Real-World Valuation Shift Marks New Berkshire Era
As Warren Buffett steps back from the spotlight, his evolving philosophy on ‘real worth’ versus book value is reshaping the investment strategy for Berkshire Hathaway under CEO Greg Abel.
-

Occidental Petroleum Navigates Post-Sale Market: OXY Stock Outlook Amid Oil Volatility & Valuation Debates
Occidental Petroleum’s $9.7 billion sale of OxyChem to Berkshire Hathaway sharpens its focus on oil and gas. We examine OXY stock’s market reaction, valuation discrepancies, and the broader energy sector’s movements.
-

Warren Buffett Retires: Lessons, Legacy, and Berkshire Hathaway’s Next Chapter
Warren Buffett retires in 2025 after shaping Berkshire Hathaway into a $1 trillion powerhouse. His annual letters offer timeless investing wisdom, while investors eye new opportunities under incoming CEO Greg Abel.
-

Todd Combs Departs Berkshire Hathaway for JPMorgan’s $1.5 Trillion Security Initiative
Todd Combs, a pivotal figure in Berkshire Hathaway’s investment strategy and CEO of Geico, leaves to lead JPMorgan’s ambitious Security and Resiliency Initiative, raising critical questions about the future of Berkshire’s portfolio management as Warren Buffett prepares to step aside.
-

Alphabet Stock Soars After Berkshire Hathaway Stake: What’s Driving Google’s Rally in 2025?
Alphabet’s stock price jumped after Berkshire Hathaway revealed a multi-billion dollar stake, marking a turning point in investor confidence and AI leadership. With strong analyst ratings and anticipation for Gemini 3.0, Alphabet is at the center of Wall Street’s tech…
-

Berkshire Hathaway’s $4.3 Billion Investment Signals Confidence in Alphabet (GOOGL) Stock
Berkshire Hathaway has revealed a substantial $4.3 billion stake in Alphabet (GOOGL), marking a significant endorsement of the tech giant’s prospects and a strategic shift for Warren Buffett’s investment portfolio.
-

Warren Buffett Steps Down: Farewell Letter, Succession, and $1.35B Share Donation Signal End of an Era
Warren Buffett bids farewell as Berkshire Hathaway CEO with a candid letter, hands the reins to Greg Abel, and accelerates philanthropy by donating $1.35 billion in shares, marking a historic transition for the iconic conglomerate.
-

Berkshire Hathaway’s $9.7 Billion OxyChem Acquisition Signals Buffett Era’s End
Berkshire Hathaway’s purchase of OxyChem for $9.7 billion marks its largest deal in years and may be Warren Buffett’s final major move as CEO, reflecting a strategic shift and leadership transition.
